fashion -WSS

fashion

author：leisure time 2025-10-01 14:14:49 - browse：65

The building exterior of AstraZeneca, a pharmaceutical and biopharmaceutical company, under cloudless blue sky — coverage from STAT — Adobe

WILMINGTON, Del. — Wednesday was the first time that a federal judge asked questions in-person of drug industry lawyers who are trying to stop Medicare from negotiating drug prices. It didn’t go well for them.

AstraZeneca’s lawyers argued that Medicare’s new powers amount to a taking of their property rights without due process. But Colm Connolly, chief judge of the U.S. District Court of Delaware, said he doesn’t understand how the law deprives AstraZeneca of its property. He asked Catherine Stetson, who represents AstraZeneca, multiple times to explain what property the company would lose due to Medicare price negotiation. Stetson said it’s both the patent and the drug that’s subject to the patent.

“You’re free to do what you want,” Connolly said, adding that drug companies don’t have to sell to Medicare. “You may not make as much money.”

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： The cancer drug shortage isn’t new — and neither are the solutions
Next article： A virus, fished out of a lake, may have saved a man’s life

WSS

Histogen: Failed biotech offers rare public look inside

3 questions for the future of Biden's cancer moonshot

FDA official pushes for dedicated emerging pathogens team

AbbVie dramatically boosts its spending on lobbying

The future of health care in the House

Elizabeth Warren probes abortion access

focus

fashion

hotspot

Medicare details structure of new drug price negotiation program

Why Charlie Gard's case is so disturbing to Americans

Medical records are filled with copy

FDA authorizes Novavax’s updated Covid

Supreme Court strikes down use of affirmative action

AbbVie dramatically boosts its spending on lobbying

Novavax promises a turnaround & Lilly roils the obesity market

In $4.8 billion deal, Bristol Myers Squibb to buy cancer player Mirati

Psychedelics group wrestles with new pharma identity

The future of health care in the House

Wikipedia

Hyaluronic acid injections don’t help knee osteoarthritis, study finds

Bristol 'take

Death toll from an explosion and collapse of a Paris building in June climbs to 3

Contact tracing may help avoid another lockdown. Can it work in the U.S.?

How artificial intelligence is being used to detect, treat cancer

Histogen: Failed biotech offers rare public look inside

focus

Wikipedia

hotspot

focus